The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

Analyze the CGDV ETF: strategy vs. “dividend value” label, returns vs. SPY, earnings growth, valuation risk, overlap, and low ...

The 2026 NFL Draft order is set for the top 18 picks. With the postseason on the way and lots of coaching changes, here's our ...

Our updated two-round NBA Mock Draft projections include an Indiana Pacers heist, a dangerous Oklahoma City Thunder addition, ...

Fort Hill’s Casey Martz (60) bolts to his left after centering the ball to quarterback Noah House during the Sentinels’ home ...

The fact that the complement system is activated during immune-complex glomerular disease has been known for nearly 50 years. Detection of complement deposition in the glomerulus using immunochemistry ...

Wireless power banks keep getting faster and slimmer, and at CES, ESR introduced its new 10K MagSlim Power Bank, which it ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

In the second part of this series, the focus shifts to partners — external forces whose alignment, trust and intent decide ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in ...

The crypto market in January 2026 feels like a pressure chamber. Prices move fast, narratives rotate faster, and investors ...